IT1396436B1 - Composizione per la prevenzione ed il trattamento delle patologie odontostomatologiche degli animali e relativi usi. - Google Patents

Composizione per la prevenzione ed il trattamento delle patologie odontostomatologiche degli animali e relativi usi.

Info

Publication number
IT1396436B1
IT1396436B1 ITMI2009A002010A ITMI20092010A IT1396436B1 IT 1396436 B1 IT1396436 B1 IT 1396436B1 IT MI2009A002010 A ITMI2009A002010 A IT MI2009A002010A IT MI20092010 A ITMI20092010 A IT MI20092010A IT 1396436 B1 IT1396436 B1 IT 1396436B1
Authority
IT
Italy
Prior art keywords
odontostomatological
disorders
animals
prevention
treatment
Prior art date
Application number
ITMI2009A002010A
Other languages
English (en)
Inventor
Gennaro Falanga
Original Assignee
Icf Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icf Srl filed Critical Icf Srl
Priority to ITMI2009A002010A priority Critical patent/IT1396436B1/it
Priority to ES10191089.1T priority patent/ES2533624T3/es
Priority to EP10191089.1A priority patent/EP2322161B1/en
Publication of ITMI20092010A1 publication Critical patent/ITMI20092010A1/it
Application granted granted Critical
Publication of IT1396436B1 publication Critical patent/IT1396436B1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/133Amines having hydroxy groups, e.g. sphingosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43Guanidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ITMI2009A002010A 2009-11-16 2009-11-16 Composizione per la prevenzione ed il trattamento delle patologie odontostomatologiche degli animali e relativi usi. IT1396436B1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI2009A002010A IT1396436B1 (it) 2009-11-16 2009-11-16 Composizione per la prevenzione ed il trattamento delle patologie odontostomatologiche degli animali e relativi usi.
ES10191089.1T ES2533624T3 (es) 2009-11-16 2010-11-12 Composición para prevenir y tratar patologías odontoestomatológicas de los animales
EP10191089.1A EP2322161B1 (en) 2009-11-16 2010-11-12 Composition for preventing and treating odontostomatological pathologies of animals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2009A002010A IT1396436B1 (it) 2009-11-16 2009-11-16 Composizione per la prevenzione ed il trattamento delle patologie odontostomatologiche degli animali e relativi usi.

Publications (2)

Publication Number Publication Date
ITMI20092010A1 ITMI20092010A1 (it) 2011-05-17
IT1396436B1 true IT1396436B1 (it) 2012-11-23

Family

ID=42335162

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2009A002010A IT1396436B1 (it) 2009-11-16 2009-11-16 Composizione per la prevenzione ed il trattamento delle patologie odontostomatologiche degli animali e relativi usi.

Country Status (3)

Country Link
EP (1) EP2322161B1 (it)
ES (1) ES2533624T3 (it)
IT (1) IT1396436B1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11273113B2 (en) 2012-04-27 2022-03-15 Stichting Vu Protection of materials by sphingosine based compounds
CN119390593A (zh) * 2024-09-26 2025-02-07 优然创新(北京)技术研发中心有限公司 一种鞘氨醇超分子体及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA99349B (en) * 1999-01-19 1999-09-29 M S Lekar Pharma Ltd A pharmaceutical formulation.
KR100314789B1 (ko) * 1999-11-05 2001-11-17 김현준 충치 예방 및 구강내 염증 치료용 치약 조성물
US6518252B2 (en) * 2000-09-20 2003-02-11 University Of Georgia Research Foundation, Inc. Method of treating aquatic animals with an antimicrobial agent and chelating agent
US20050064019A1 (en) * 2003-02-10 2005-03-24 Hill Ira D. Impregnated, flexible, rawhide pet chews containing antimicrobially active chlorhexdine
ES2214135B1 (es) * 2003-02-21 2005-05-01 Laboratorios Kin S.A. Composicion para el tratamiento de la cavidad bucal y utilizaciones correspondientes.
WO2004096140A2 (en) * 2003-04-25 2004-11-11 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
EP2092834A1 (en) * 2008-02-19 2009-08-26 Innopact B.V. Methods and compositions of sphingolipid for preventing treating microbial infections

Also Published As

Publication number Publication date
EP2322161B1 (en) 2014-12-31
ITMI20092010A1 (it) 2011-05-17
EP2322161A1 (en) 2011-05-18
ES2533624T3 (es) 2015-04-13

Similar Documents

Publication Publication Date Title
HUE046610T2 (hu) Probiotikus készítmény kutyák gyomor-bélrendszeri rendellenességeinek megelõzésére vagy kezelésére
PL2504005T3 (pl) Zastosowanie pochodnych 1,3-difenyloprop-2-en-1-onu do leczenia zaburzeń wątroby
SMT201600055B (it) Composizione farmaceutica per il trattamento o la prevenzione del glaucoma
HUE061548T2 (hu) Komplementtel összefüggõ rendellenességek kezelésére szolgáló eljárások és készítmények
BRPI1012116A2 (pt) composição farmacêutica para o tratamento de doenças cardíacas
BRPI0807987A2 (pt) Terapia de combinação para tratamento de distúrbios imunes.
BRPI0924425A2 (pt) "combinações de substâncias ativas sinergéticas".
SMP200900085B (it) 3-imidazolil-indoli per il trattamento di malattieproliferative.
BRPI1009372A2 (pt) compostos, composição farmacêutica e respectivos usos
DK2451796T3 (da) Tofaanaloger til behandling af dermatologiske lidelser eller tilstande
PL2338519T3 (pl) Środek do leczenia zwłóknienia szpiku
HUE040085T2 (hu) PDE7 inhibitorok alkalmazása mozgási rendellenességek kezelésére
BRPI0911577A8 (pt) derivados espiro-indol para o tratamento de doenças parasíticas.
ZA201102640B (en) Use of scyllo-inositols for the treatment of macular degeneration-related disorders
IL209336B (en) Compositions for treating hyperproliferative diseases and uses thereof
BRPI1009783A2 (pt) compostos para o tratamento de distúrbios metabólicos.
IT1391866B1 (it) Composizione iniettabile di polinucleotidi per il trattamento di patologie osteoarticolari.
BRPI1007929A2 (pt) "métodos e composições para o tratamento de neovascularização".
IT1399148B1 (it) Impianto per la realizzazione di artocoli igienici intimi.
BRPI0914139A2 (pt) composições pediátricas para o tratamento de esclerose múltipla
ES2445016B1 (es) Vacuna para el tratamiento/la prevencion de escuticociliatosis en peces
HU0900231D0 (en) Compositions for the treatment of allergic disorders
BR112013007039A2 (pt) "composição de tratamento pessoal"
IT1396436B1 (it) Composizione per la prevenzione ed il trattamento delle patologie odontostomatologiche degli animali e relativi usi.
BRPI0911920A2 (pt) derivados de 1-amino-alquilciclohexano para o tratamento de distúrbios do sono